NCT01038518

Brief Summary

The overall aim of the Health2010-14 is to monitor the prevalence and trends of common chronic diseases (osteoporosis, diabetes, cardiovascular disease, asthma, allergy, and eczema) that are often un-diagnosed in the general population as well as biomarkers of micronutrient status. Specific aims include identification of novel lifestyle and genetic risk factors for the above diseases by investigating gene-lifestyle interactions.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,522

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2010

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 22, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 24, 2009

Completed
10 months until next milestone

Study Start

First participant enrolled

November 1, 2010

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
Last Updated

January 22, 2015

Status Verified

January 1, 2015

Enrollment Period

9 months

First QC Date

December 22, 2009

Last Update Submit

January 21, 2015

Conditions

Cardiovascular DiseaseType 2 DiabetesAsthmaAllergyOsteoporosis

Keywords

epidemiologyrisk factorsmicronutrients

Outcome Measures

Primary Outcomes (1)

  • 5-year change in prevalence of biomarkers of chronic diseases (e.g. diabetes, asthma, allergy) and micronutrient status (e.g. vitamin D status).

    5 years

Secondary Outcomes (1)

  • significant interaction (on a additive scale) between Vitamin D status and genetic variants in the Vitamin D receptor in relation to selected chronic disease biomarkers

    5 years

Study Arms (1)

Health2010

Cross-sectional general population study

Eligibility Criteria

Age18 Years - 72 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Random samples of persons living in 10 municipalities in the Western part of the Capital Region of Denmark (Copenhagen).

You may qualify if:

  • persons living in 10 municipalities of Copenhagen

You may not qualify if:

  • pregnancy, non-Danish citizenship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Urine, serum, whole blood, extracted DNA

MeSH Terms

Conditions

Cardiovascular DiseasesDiabetes Mellitus, Type 2AsthmaHypersensitivityOsteoporosis

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateImmune System DiseasesBone Diseases, MetabolicBone DiseasesMusculoskeletal Diseases

Study Officials

  • Allan Linneberg, MD, PhD

    Research Center for Prevention and Health, Glostrup Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Head of Section

Study Record Dates

First Submitted

December 22, 2009

First Posted

December 24, 2009

Study Start

November 1, 2010

Primary Completion

August 1, 2011

Study Completion

August 1, 2011

Last Updated

January 22, 2015

Record last verified: 2015-01